A Study to Explore the Role and Impact of Wearable Smart Devices in Perioperative NSCLC Patients

Non Small Cell Lung Cancer Clinical Trial

Official title:

A Prospective Observational Study to the Role and Impact of Wearable Smart Devices in Perioperative NSCLC Patients

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06118229
• Other study ID #: WISP-NSCLC
• Status: Recruiting
• Start date: March 9, 2023
• Est. completion date: June 30, 2024

Study information

• Verified date: November 2023
• Source: The First Affiliated Hospital of Guangzhou Medical University
• Contact: Jianxing He, M.D
• Phone: +86-20-83337792
• Email: drjianxing.he[@]gmail.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The trial was designed as a single-center non-interventional prospective observational study to explore the role and impact of wearable smart devices in perioperative NSCLC patients.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 300
• Est. completion date: June 30, 2024
• Est. primary completion date: December 31, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. Participants must provide voluntary consent to participate in this research and possess the capacity to sign an informed consent form.

2. Participants must be aged over 18 years.

3. Participants must have undergone pulmonary resection surgery with a postoperative pathological confirmation of primary lung cancer.

Exclusion Criteria:

1. Patient refusal to participate in this research.

2. Inability to wear wearable smart monitoring devices due to various reasons.

3. Pathological reports suggesting non-small cell lung cancer (NSCLC).

4. History of secondary lung cancer surgery.

Related Conditions & MeSH terms

• Carcinoma, Non-Small-Cell Lung
• Non Small Cell Lung Cancer

Intervention

Device:
• Wearable smart devices and PROs
Patients wearing wearable smart devices to monitor physiological data while regularly utilizing PROs to report subjective assessments of their own health status.

Locations

Country	Name	City	State
China	Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University	Guangzhou	Guangdong

Sponsors (1)

Lead Sponsor	Collaborator
The First Affiliated Hospital of Guangzhou Medical University

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Postoperative length of hospital stay	Postoperative Length of Stay (LOS) refers to the duration of a patient's hospitalization following surgery, typically measured from the completion of the surgical procedure to the time of patient discharge.	From time of surgery to time of discharge from the hospital (assessed up to 30 days)
Secondary	Operative time	Operative time is defined as the time from the start of the surgical procedure to its completion, including anesthesia induction, surgical incision, manipulation of tissues, closure, and completion of all surgical tasks.	From time of the start of surgery to the end of surgery